Our data clearly establish that the co-expression of apelin and APJ by pancreatic tumor cells fosters tumor growth, whereas loss of the apelin receptor dramatically reduces the tumor burden in murine orthotopic xenograft experiments. This evidence concerns the gene APLNR and pancreatic neoplasm.